News

This review of the latest dermatological studies includes insights on pediatric teledermatology rates pre- and post-COVID, a 10-peptide face serum for skin quality, AI-automated disease scoring, and more.

Needle-free botulinum toxin microjet TDA delivery cuts facial oil up to 40%, refines pores, and boosts confidence without bruising or downtime in acne patients.

A prospective study found that patch testing identified relevant allergens in 43% of patients with hand and foot eczema, with potassium dichromate being the most common sensitizer.

A new study reveals gaps in acne management for teens with PCOS; Hispanic patients are less likely to receive spironolactone, COCs, or isotretinoin treatment.

Red light–activated photodynamic therapy offers an effective field-based option for treating both visible and subclinical actinic keratoses.

Douglas DiRuggiero, DMSc, MHS, PA-C, emphasized that relying solely on body surface area underestimates psoriasis burden, particularly for patients with disease in high-impact or special areas.

Real-world data show IL-17 biologics rapidly improve special-site psoriasis and quality of life, as researchers identified predictors of PASI75/90 response.

Dylan Timmermann, PA-C, reflects on the experiences that shaped his career trajectory in dermatology and offers insights relevant to physician assistants and nurse practitioners entering the specialty.

A survey of dermatology residents found that interest in subspecialty fellowships often declines during training, with financial concerns particularly affecting pediatric dermatology.

NFBC1966 data from Finland show that hand eczema is associated with poorer self-rated work ability among middle-aged adults, particularly among those with certain risk factors.

Patients treated with deucravacitinib achieved higher ACR20 response rates at week 16 than those receiving placebo in the POETYK PsA studies.

A newly defined Nodularity Index, measuring tumor depth relative to width, independently predicted melanoma-specific survival.

A cover feature by Nicole A. Negbenebor, MD, FAAD, examines the growing leadership role of women in Mohs micrographic surgery for nonmelanoma skin cancer.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.

In case you missed it, this week we had news on the end of late-stage rocatinlimab OX40 development, FDA priority review of brepocitinib for dermatomyositis, phase 3 trial data of cemiplimab, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

O’Donoghue, a respected dermatologist and educator, left a lasting impact through her leadership, scholarship, and dedication to family and faith.

In the latest Cutaneous Connection podcast episode, Doris Day, MD, FAAD, offers practical guidance for clinicians looking to incorporate discussions of hormonal health into aesthetic consultations with menopausal patients.

At week 16, 73.3% of patients receiving delgocitinib achieved a clinically meaningful improvement (≥ 4 points) in Dermatology Life Quality Index score vs 47.8% with vehicle.

Explore PDPA’s 2025 compensation survey, revealing dermatology PA salary trends, workload patterns, benefits insights, and job satisfaction across the state of Pennsylvania.

The on-demand format of podcasts allows learners at all levels to engage with expert insights conveniently.

Catch up on coverage from this year's Winter Clinical Miami meeting.

This FAQ answers top questions of HS therapy: when to escalate to biologics, add surgery, measure success, and support mental health.

Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, highlighted that CHE is often mischaracterized and frequently involves overlapping subtypes.

At Winter Clinical Miami 2026, Andrew F. Alexis, MD, MPH, shares skin-of-color therapy pearls as Clay Cockerell, MD, spotlights must-biopsy mimickers.

The reimagined Don’t Be Rash podcast positions industry leaders at the center of pediatric skin conversations.

Clearance rates increased between days 29 and 57, with the highest activity observed in the 200-μg treatment group.

Winter Clinical Miami experts shared professional development tips and clinical pearls during the meeting's classic "15 Tips in 15 Minutes" session.

Omar Noor, MD, shares pearls on type 2 inflammation, including dupilumab insights for atopic dermatitis, prurigo nodularis, and CSU at Horizons in Advanced Practice.

Baker explains why competency-based autonomy and structured collaboration are essential in high-acuity medical dermatology.